- Stuart W. Peltz, Allan Jacobson
- South Plainfield, NJ
- Went Public on Jun 20, 2013
- Health Care, Biotechnology
- PTC Therapeutics is a biopharmaceutical company that engages in the discovery, development and commercialization of small-molecule drugs.
PTC Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of orally administered and small-molecule drugs. It offers Ataluren, an orally administered small-molecule investigational new drug for the treatment of cystic fibrosis and duchenne muscular dystrophy caused by nonsense mutations. The company also provides PTC299, an anti-angiogenesis drug for the treatment of metastatic breast cancer, multiple tumors, and neurofibromatosis. Its products are used for the treatment of genetic disorders, oncology, and infectious diseases. PTC Therapeutics, Inc. was founded in 1998 and is based in South Plainfield, New Jersey.
Current Team (9)Update
Senior Vice President Research & CMC
Vice President, Clinical Development
Executive Vice President and Chief Legal Officer
President, Senior Vice President, Corporate Development
Board of Directors, Co - founder
Chief Financial Officer
Past Team (3)Update
Funding Rounds (9) - $177.1MUpdate
Board Members and Advisors (14)Update
Novo A/S is the holding company of the Novo Group, wholly-owned by the Novo Nordisk Foundation.
They design, implement, and manage custom tailored portfolios of liquid assets for high net worth...
Adage Capital Management is a Boston-based $8.9B Money Management firm focused on managing...
Jennison Associates has earned a reputation for excellence by fulfilling client investment needs...
Longwood Founders Fund was founded in 2010
Multinational financial services company
Vulcan Capital invests across all stages of corporate development through leveraged buyouts,...
Venture capital Firm
100 Corporate Court
South Plainfield, NJ 07080-2449